Illumina, Inc.

Headquarters: San Diego, CA, United States

Founded: 1998

Employees: 9,800

CEO: Mr. Francis A. deSouza

show_chart NASDAQ: ILMN +3.81%

Market Cap

$31.60 Billion

USD as of Jan. 1, 2023

history Market Cap History

Company Description

Illumina, Inc. is a biotechnology company specialized in DNA sequencing. It develops, manufactures, and markets genetic and biological analysis systems dedicated to the markets of gene sequencing, genotyping and gene expression, and proteomics. Thanks to its products, Illumina has been able to dramatically reduce the cost of human genome sequencing.

Illumina, Inc. market capitalization over time

Evolution of Illumina, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Illumina, Inc.

Detailed Description

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.

Product & Services

NovaSeq 600HiSeq X, HiSeq 400MiSeq, MiSeqDx, MiniSeq, iSeq 10NextSeq 55NextSeq 550Dx, iScan

Key People

Founder(s): David Walt Larry Bock John Stuelpnagel Anthony Czarnik Mark Chee

Francis de Souza (President & CEO) John W. Thompson (Board Chair) Sam Samad (CFO)


Revenue: US$1.093 Billion (Fiscal Year Ended January 3, 2021)

Operating income: US$0.580 Billion (Fiscal Year Ended January 3, 2021)

Net income: US$0.656 Billion (Fiscal Year Ended January 3, 2021)

Total assets: US$7.585 Billion (Fiscal Year Ended January 3, 2021)

Total equity: US$4.694 Billion (Fiscal Year Ended January 3, 2021)



5200 Illumina Way

San Diego, CA 92122

United States

Phone: 858 202 4500

Fax: 858 202 4545